One study showed that treatment of human cell lines with TGF-β results in epigenetic activation through promoter demethylation of genes such as slug and urokinase plasminogen activator receptor (CD87), resulting in increased cancer stemness [29]. The gene discussed is TGFB1; the disease is cancer.